Scheme 1.
The concept of conferring immune-inhibitory properties using CD200-coated surfaces. Traditional biomaterials non-specifically adsorb proteins, which activate immune cells. Immunomodulatory biomaterials displaying CD200 will bind to CD200R and activate inhibitory pathways to prevent immune cell activation.
